Financial Statements — PBLS
Balance Sheet
(in billions USD)| Metric | Q2
2026 |
|---|
| Cash & Equivalents | 1.09 |
| Short-term Investments | 0.03 |
| Total Current Assets | 1.13 |
| Property, Plant & Equipment | 0.01 |
| Total Non-current Assets* | 0.05 |
| Total Assets | 1.18 |
| Accounts Payable | 0.02 |
| Short-term Debt | 0.01 |
| Total Current Liabilities | 0.06 |
| Long-term Debt | 0.00 |
| Total Non-current Liabilities* | 0.06 |
| Total Liabilities | 0.13 |
| Retained Earnings | (0.64) |
| Total Stockholder Equity | 1.05 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 |
|---|
| Total Revenue | 0.15 |
| Research & Development | 39.38 |
| Selling, General & Admin | 11.66 |
| Total Operating Expenses | 51.03 |
| Operating Income | (50.89) |
| Net Income | (52.46) |
| Basic EPS | (2.32) |
| Diluted EPS | (2.32) |
Cash Flow Statement
(in billions USD)| Metric | Q2
2026 |
|---|
| Operating Cash Flow | (0.05) |
| Capital Expenditures | 0.00 |
| Free Cash Flow* | (0.05) |
| Investing Cash Flow | (0.03) |
| Financing Cash Flow | 1.15 |
* Derived from reported values
